+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Search Bar & Filters

Found 2 Actively Recruiting clinical trials

C

Actively Recruiting

Researchers are evaluating the effects of aerobic exercise compared to digital cognitive behavioral therapy for insomnia CBT-I in university students who have complaints of insomnia. The study aims to see if aerobic exercise can produce similar improvements as digital CBT-I in reducing insomnia severity and improving sleep quality, as well as reducing symptoms of depression, anxiety, and stress. This is a clinical trial sponsored by Universidade Federal de Goias with randomized participant groups. Participants will be divided into two groups one group will engage in aerobic exercise consisting of three outdoor walking sessions per week, each lasting 50 continuous minutes at moderate intensity, for 7 weeks. These sessions will be supervised and recorded by a researcher. The second group will participate in three weekly sessions of digital CBT-I via the Vigilantes do Sono app, which follows an approved therapeutic protocol. During the study, participants will complete self-administered questionnaires to assess insomnia severity, sleep quality, cognitive and somatic arousal before sleep, and symptoms of depression, anxiety, and stress both at the start and after 7 weeks of intervention. Additional evaluations include physical assessments, sleep diaries, physical activity levels, and sedentary behavior. Researchers will monitor adherence to the interventions and collect data to compare outcomes between the two groups.

Age: 18Years +All GendersPhase Not Applicable
1 location
E

Actively Recruiting

Researchers are evaluating Cognitive Behavioral Therapy for Insomnia CBT-I to treat insomnia complaints in physically active men and women aged 30 to 59 years. The study aims to determine if CBT-I can reduce the severity of insomnia and improve sleep quality and related complaints. This randomized clinical trial compares CBT-I against no treatment to assess its effects on better sleep. Participants will be randomly assigned to one of two groups a treatment group receiving 6 weeks of CBT-I, which includes sleep restriction, cognitive therapy, stimulus control, sleep hygiene, and relaxation therapy, and a control group receiving no treatment. The study will run from November 2025 to December 2028, with assessments at baseline, after 6 weeks of treatment, and after a 4-week follow-up period. Throughout the study, participants will complete self-administered questionnaires assessing sleep, physical activity, mood, quality of life, and other related factors. Sleep will also be monitored using actigraphy. Researchers will measure insomnia severity at three points before treatment, after treatment, and after follow-up. The total study duration for each participant is up to 13 weeks, with privacy and confidentiality strictly maintained.

Age: 30Years - 59YearsAll GendersPhase Not Applicable
1 location